Cullen/Frost Bankers’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.14K Hold
16
﹤0.01% 1300
2025
Q4
$947 Hold
16
﹤0.01% 1310
2025
Q3
$883 Sell
16
-36
-69% -$1.87K ﹤0.01% 1271
2025
Q2
$2.24K Sell
52
-153
-75% -$5.9K ﹤0.01% 1167
2025
Q1
$8.12K Buy
+205
New +$9.07K ﹤0.01% 979
2020
Q3
Sell
-100
Closed -$5K 1232
2020
Q2
$5K Buy
+100
New +$4.75K ﹤0.01% 964
2019
Q2
Sell
-1
Closed 1086
2019
Q1
$0 Buy
+1
New +$100 ﹤0.01% 956

Other funds holding NGVT

Cullen/Frost Bankers's NGVT Position: Q1 2026 in Review

Cullen/Frost Bankers held its Ingevity (NGVT) position steady in Q1 2026 at 16 shares worth $1.14K. The position accounts for ﹤0.01% of the portfolio, ranked #1300.

Cullen/Frost Bankers first reported a position in NGVT in Q1 2019 and has held it in 7 quarters since. The position peaked at $8.12K in Q1 2025. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Cullen/Frost Bankers held 16 shares of Ingevity worth $1.14K as of Q1 2026.
  • Cullen/Frost Bankers left its Ingevity share count unchanged in Q1 2026.
  • Ingevity made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q1 2026, its #1300 holding.
  • Cullen/Frost Bankers first reported a position in Ingevity in Q1 2019 and has held it in 7 quarters since.
  • Cullen/Frost Bankers's Ingevity position peaked at $8.12K in Q1 2025.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Cullen/Frost Bankers's 13F filing for Q1 2026, filed 5 May 2026.